BIO-TECHNE Corp (TECH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q4 '21: 259M Q1 '22: 257.7M Q2 '22: 269.3M Q3 '22: 290.4M Q4 '22: 288.2M Q1 '23: 269.7M Q2 '23: 271.6M Q3 '23: 294.1M Q4 '23: 301.3M Q1 '24: 276.9M Q2 '24: 272.6M Q3 '24: 303.4M Q4 '24: 306.1M Q1 '25: 289.5M Q2 '25: 297M Q3 '25: 316.2M Q4 '25: 317M Q1 '26: 286.6M Q2 '26: 295.9M Q3 '26: 311.4M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 80M 160M 240M Q4 '21: 175.9M Q1 '22: 171M Q2 '22: 183.7M Q3 '22: 201.5M Q4 '22: 200.3M Q1 '23: 179.6M Q2 '23: 183.4M Q3 '23: 202.2M Q4 '23: 204.7M Q1 '24: 185.2M Q2 '24: 176.6M Q3 '24: 204.6M Q4 '24: 203.3M Q1 '25: 183M Q2 '25: 193.9M Q3 '25: 214.6M Q4 '25: 198.8M Q1 '26: 188.1M Q2 '26: 191.3M Q3 '26: 208.3M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income Quarterly

0 35M 70M 105M Q3 '21: 68.6M Q4 '21: 68.6M Q1 '22: 63.2M Q2 '22: 62.3M Q3 '22: 90.4M Q4 '22: 80.6M Q1 '23: 56.3M Q2 '23: 67.9M Q3 '23: 80.2M Q4 '23: 94.5M Q1 '24: 55.9M Q2 '24: 38M Q3 '24: 67M Q4 '24: 45.8M Q1 '25: 40M Q2 '25: 47.4M Q3 '25: 38.7M Q1 '26: 47.7M Q2 '26: 54.5M Q3 '26: 75.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Net Income Quarterly

0 35M 70M 105M Q3 '21: 45.8M Q4 '21: 15M Q1 '22: 69.6M Q2 '22: 80.2M Q3 '22: 60.7M Q4 '22: 61.5M Q1 '23: 89.6M Q2 '23: 50M Q3 '23: 70.2M Q4 '23: 75.5M Q1 '24: 51M Q2 '24: 27.5M Q3 '24: 49.1M Q4 '24: 40.6M Q1 '25: 33.6M Q2 '25: 34.9M Q3 '25: 22.6M Q1 '26: 38.2M Q2 '26: 38M Q3 '26: 51M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Cost of Revenue Quarterly

0 50M 100M 150M Q4 '21: 83.1M Q1 '22: 86.7M Q2 '22: 85.6M Q3 '22: 88.9M Q4 '22: 87.9M Q1 '23: 90.1M Q2 '23: 88.2M Q3 '23: 92M Q4 '23: 96.6M Q1 '24: 91.7M Q2 '24: 96M Q3 '24: 98.8M Q4 '24: 102.8M Q1 '25: 106.4M Q2 '25: 103.1M Q3 '25: 101.6M Q4 '25: 118.2M Q1 '26: 98.4M Q2 '26: 104.6M Q3 '26: 103.1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow Quarterly

0 50M 100M 150M Q4 '21: 122M Q1 '22: 48.4M Q2 '22: 101M Q3 '22: 73.1M Q4 '22: 102.7M Q1 '23: 56.1M Q2 '23: 64.4M Q3 '23: 50.5M Q4 '23: 83.4M Q1 '24: 59.4M Q2 '24: 83.1M Q3 '24: 81M Q4 '24: 75.5M Q1 '25: 63.9M Q2 '25: 84.3M Q3 '25: 41.1M Q4 '25: 98.2M Q1 '26: 27.6M Q2 '26: 82.4M Q3 '26: 86.7M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

0 40M 80M 120M Q4 '21: 110.7M Q1 '22: 42.4M Q2 '22: 90.8M Q3 '22: 58M Q4 '22: 89.1M Q1 '23: 46.5M Q2 '23: 58.3M Q3 '23: 38.8M Q4 '23: 72.6M Q1 '24: 45.8M Q2 '24: 68.3M Q3 '24: 64.5M Q4 '24: 57.5M Q1 '25: 54.7M Q2 '25: 77.5M Q3 '25: 31M Q4 '25: 93.3M Q1 '26: 22.2M Q2 '26: 76.5M Q3 '26: 77.6M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '20: 39.4M Q4 '20: 39.7M Q1 '21: 40M Q2 '21: 40.3M Q3 '21: 40.7M Q1 '22: 41.2M Q2 '22: 164.8M Q3 '22: 163.9M Q1 '23: 162.2M Q2 '23: 161.8M Q3 '23: 161.6M Q1 '24: 161.9M Q2 '24: 160.1M Q3 '24: 160.5M Q1 '25: 161.1M Q2 '25: 160.6M Q3 '25: 158.9M Q1 '26: 156.4M Q2 '26: 157M Q3 '26: 157.4M Q4 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q4 '19: 2.47 Q1 '20: 2.39 Q2 '20: 4.96 Q3 '20: 4.73 Q4 '20: 5.79 Q1 '21: 6.25 Q2 '21: 4.38 Q3 '21: 4.58 Q4 '22: 2.93 Q1 '23: 1.79 Q2 '23: 1.61 Q3 '23: 1.67 Q4 '23: 1.75 Q1 '24: 1.51 Q2 '24: 1.37 Q3 '24: 1.25 Q4 '24: 1.05 Q1 '25: 0.95 Q2 '25: 1.00 Q3 '25: 0.83 Q1 '20 Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.